Teva completes Rimsa buyout

08-03-2016

Teva completes Rimsa buyout

Photo: Courtesy of Teva

Pharmaceutical company Teva has bought Mexico-based Representaciones e Investigaciones Médicas (Rimsa), in a deal totalling $2.3 billion (£1.6 billion).


Teva, Rimsa, mergers & acquisitions, pharmaceutical, IP, patent, Erez Vigodman, patent, Representaciones e Investigaciones Médicas,

LSIPR